We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$672M
AUM Growth
+$9.24M
Cap. Flow
+$9.33M
Cap. Flow %
1.39%
Top 10 Hldgs %
14.36%
Holding
888
New
17
Increased
717
Reduced
97
Closed
45

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.09M
2
MSFT icon
Microsoft
MSFT
+$691K
3
AGN
Allergan plc
AGN
+$636K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$626K
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$510K

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.72M
2
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$1.45M
3
FRX
FOREST LABORATORIES INC
FRX
+$687K
4
QCOR
QUESTCOR PHARMA INC
QCOR
+$607K
5
HSH
HILLSHIRE BRANDS CO
HSH
+$590K

Sector Composition

Rank Sector Weight
1 Technology 14.68%
2 Healthcare 14.01%
3 Financials 12.28%
4 Industrials 11.44%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCEL icon
826
FuelCell Energy
FCEL
$1.7B
$45K 0.01%
5
– –
SD
827
DELISTED
SANDRIDGE ENERGY, INC.
SD
$44K 0.01%
10,334
+87
+0.8% +$486
ZNGA
828
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$41K 0.01%
15,096
+122
+0.8% +$365
RTK
829
DELISTED
Rentech, Inc.
RTK
$38K 0.01%
2,221
-1
-0% -$22
ARRY
830
DELISTED
Array Biopharma Inc
ARRY
$36K 0.01%
10,195
+5
+0% +$20
CGRN
831
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$34K 0.01%
161
+1
+0.6% +$256
SQNM
832
DELISTED
SEQUENOM INC NEW
SQNM
$34K 0.01%
11,351
-6
-0.1% -$22
CTIC
833
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$32K ﹤0.01%
1,309
– –
EXEL icon
834
Exelixis
EXEL
$13.9B
$29K ﹤0.01%
18,988
-9
-0% -$29
LXRX icon
835
Lexicon Pharmaceuticals
LXRX
$1.02B
$29K ﹤0.01%
2,914
+11
+0.4% +$117
RXII
836
DELISTED
GALENA BIOPHARMA INC COM
RXII
$24K ﹤0.01%
11,507
-9
-0.1% -$19
DNDN
837
DELISTED
DENDREON CORPORATION
DNDN
$23K ﹤0.01%
15,666
+58
+0.4% +$102
CDMO
838
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$22K ﹤0.01%
2,318
+9
+0.4% +$101
ATRS
839
DELISTED
Antares Pharma, Inc.
ATRS
$21K ﹤0.01%
11,386
-4
-0% -$9
NAVB
840
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$16K ﹤0.01%
592
+3
+0.5% +$79
ZGNX
841
DELISTED
Zogenix, Inc.
ZGNX
$14K ﹤0.01%
1,496
+6
+0.4% +$68
QMCO icon
842
Quantum Corp
QMCO
$437M
$12K ﹤0.01%
65
+1
+2% +$199
ABG icon
843
Asbury Automotive
ABG
$4.19B
– –
-2,992
Closed -$206K
CE icon
844
Celanese
CE
$5.09B
– –
-3,250
Closed -$209K
CXT icon
845
Crane NXT
CXT
$3.04B
– –
-7,963
Closed -$206K
DAN icon
846
Dana Inc
DAN
$2.91B
– –
-8,558
Closed -$209K
FICO icon
847
Fair Isaac
FICO
$28.7B
– –
-3,490
Closed -$223K
FUL icon
848
H.B. Fuller
FUL
$3B
– –
-4,888
Closed -$235K
FWONA icon
849
Liberty Media Series A
FWONA
$22.3B
– –
-11,067
Closed -$269K
GRMN
850
Garmin
GRMN
$46.9B
– –
-3,533
Closed -$215K
32 33
34
35 36

Similar funds

Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

Amalgamated Bank's Q3 2014 Portfolio in Review

As of Q3 2014, Amalgamated Bank held 888 positions worth $672M, up 1.4% from $663M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Amalgamated Bank's Q3 2014 filing shows 17 new, 717 increased, 97 reduced and 45 closed positions. Its largest new stake was Puma Biotechnology: 2,264 shares worth $540K. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.72M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Amalgamated Bank's largest Q3 2014 buy was Puma Biotechnology: 2,264 shares worth $540K.
  • Amalgamated Bank added most to Apple in Q3 2014, an estimated $1.09M increase.
  • Amalgamated Bank's biggest Q3 2014 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.72M.
  • Amalgamated Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $687K.
  • Amalgamated Bank's ten largest holdings make up 14% of its $672M portfolio in Q3 2014.
  • Amalgamated Bank opened 17 new positions and closed 45 in Q3 2014.
  • Amalgamated Bank's portfolio value rose 1.4% quarter-over-quarter to $672M.

Based on Amalgamated Bank's 13F filing for Q3 2014, filed 14 Nov 2014.